I think those were two different issues. One was that we were attempting to get the vaccine in order to do clinical trials to obtain more information about the use of those vaccines. As you're aware, before those vaccines could be used for emergency use and in the general population, they would need to go through phase one, phase two and phase three studies before emergency authorization would be approved for the general population, certainly in Canada and elsewhere.
We're definitely surprised any time a vaccine is authorized for use before any of those data are available, whether that be in China or.... We were similarly surprised when that occurred in Russia with the Russian vaccine, which was also authorized for general usage after only phase two studies, before phase three studies had even begun.